Compugen Stock

Compugen Equity Growth

The Year-over-Year Equity Growth of Compugen (CGEN) as of Sep 14, 2026 is 87.08 %. In the previous year, Year-over-Year Equity Growth was -16.24 % — a change of -636.27% (higher).

Equity Growth

87.08 %

YoY

-636.27%

Last updated:

Year-over-Year Equity Growth of Compugen is 2026 87.08 % . Year-over-Year Equity Growth of Compugen was 2025 -16.24 % . It decreases by -636.27% higher compared to the previous year.

The Compugen Equity Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Growth
Date
Equity Growth
Jan 1, 2018
27.12 USD
Jan 1, 2019
2.89 USD
Jan 1, 2020
212.58 USD
Jan 1, 2021
-10.93 USD
Jan 1, 2022
-27.19 USD
Jan 1, 2023
-15.60 USD
Jan 1, 2024
-16.24 USD
Jan 1, 2025
87.08 USD
The Compugen Equity Growth history
YEAREquity GrowthYoY
87.08 %-636.27%
-16.24 %+4.06%
-15.60 %-42.62%
-27.19 %+148.85%
-10.93 %-105.14%
212.58 %+7,244.10%
2.89 %-89.33%
27.12 %-150.34%
-53.88 %+83.61%
-29.34 %+93.41%
-15.17 %
Access this data via the Eulerpool API

Compugen Stock analysis

What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compugen stock

Year-over-Year Equity Growth of Compugen is 87.08 % in 2026.

On Eulerpool you can find the complete historical development of Year-over-Year Equity Growth Compugen since 2006 – with annual values, charts, and detailed analysis.

Equity growth measures the percentage change in shareholders' equity. It reflects retained earnings, share issuances, and comprehensive income effects.

To evaluate Year-over-Year Equity Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Equity Growth.

Year-over-Year Equity Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Equity Growth's Compugen historically and in real time.

Access this data via the Eulerpool API

Growth — Compugen

All Key Metrics — Compugen